By Lisa Kerner
Charlotte, N.C., June 27 - Lifeblood Medical, Inc. said it completed a $1.2 million round of series B financing with private investors. Earlier this year, the company raised $1 million in series A financing through one private investor.
Total proceeds will be used for hiring and to begin the process of seeking Food and Drug Administration approval of Lifor for organ preservation.
Located in Freehold, N.J., Lifeblood is a cell culture/biotechnology company specializing in organ, cell and tissue preservation.
| Issuer: | Lifeblood Medical, Inc.
|
| Issue: | Series B financing
|
| Amount: | $1.2 million
|
| Investors: | Private
|
| Announcement date: | June 27
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
